×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北京... [9]
复旦大学上海医学院 [4]
江苏大学 [1]
自动化研究所 [1]
中南大学 [1]
合肥物质科学研究院 [1]
更多...
内容类型
期刊论文 [12]
会议论文 [5]
发表日期
2022 [1]
2019 [1]
2018 [3]
2017 [1]
2015 [7]
2013 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共17条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
Non-invasive molecular imaging for precision diagnosis of metastatic lymph nodes: opportunities from preclinical to clinical applications
期刊论文
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 页码: 23
作者:
Cheng, Zhongquan
;
Ma, Jiaojiao
;
Yin, Lin
;
Yu, Leyi
;
Yuan, Zhu
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2023/01/09
Molecular imaging
Lymph node metastasis
Cancer
Imaging probes
Imaging biomarkers
Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III tria
期刊论文
2019
作者:
Guo Y
;
Ahn M-J
;
Chan A
;
Wang C-H
;
Kang J-H
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2020/01/03
Asian
HNSCC
afatinib
methotrexate
First-line cetuximab plus cisplatin and fluorouracil vs cisplatin and fluorouracil in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: The randomized, phase III CHANGE-2 trial
会议论文
作者:
Guo, Y.
;
Luo, Y.
;
Zhang, Q.
;
Huang, X.
;
Li, Z.
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/05
First-line cetuximab plus cisplatin and fluorouracil vs cisplatin and fluorouracil in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: The randomized, phase III CHANGE-2 trial
期刊论文
2018, 卷号: 29
作者:
Guo, Y.
;
Luo, Y.
;
Zhang, Q.
;
Huang, X.
;
Li, Z.
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
First-line cetuximab plus cisplatin and fluorouracil vs cisplatin and fluorouracil in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: The randomized, phase III CHANGE-2 trial
会议论文
ANNALS OF ONCOLOGY, 2018-11-01
作者:
Guo, Y.
;
Luo, Y.
;
Zhang, Q.
;
Huang, X.
;
Li, Z.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
期刊论文
MEDICINE, 2017, 卷号: 96, 期号: 52, 页码: e9519
作者:
Chen, Wen-Chun[1]
;
Chu, Pen-Yuan[2]
;
Lee, Yu-Ting[3]
;
Lu, Wen-Bin[4]
;
Liu, Chun-Yu[5]
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/24
anti-PD1
head and neck squamous cell carcinoma
pembrolizumab
recurrent/metastatic
Platinum‐based chemotherapy plus cetuximab first‐line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open‐label, single‐arm, multicenter trial
期刊论文
Head & Neck, 2015, 卷号: 37, 期号: 8, 页码: 1081-1087
作者:
Guo, Ye
;
Shi, Mei
;
Yang, Ankui
;
Feng, Jifeng
;
Zhu, Xiaodong
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/03
cetuximab
Chinese
EXTREME trial
head and neck cancer
recurrent and metastatic squamous cell carcinoma
Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial
期刊论文
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 卷号: 37, 期号: 8
作者:
Guo, Ye
;
Shi, Mei
;
Yang, Ankui
;
Feng, Jifeng
;
Zhu, Xiaodong
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/19
cetuximab
Chinese
EXTREME trial
head and neck cancer
recurrent and metastatic squamous cell carcinoma
Phase III study of afatinib vs methotrexate (MTX) for second-line recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients after platinum-based chemotherapy (CT) in Asia/Middle East/North Africa: LUX-Head & Neck 3 (LUX-H&N3)
会议论文
作者:
Tang, P. Z.
;
Ahn, M. -J.
;
Zhang, Q.
;
Chan, A.
;
Kim, S. -B.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/19
Phase III study of afatinib vs methotrexate (MTX) for second-line recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients after platinum-based chemotherapy (CT) in Asia/Middle East/ North Africa: LUX-Head & Neck 3 (LUX-H&N3)
期刊论文
Annals of Oncology, 2015
作者:
Tang P.Z., Ahn M.-J., Zhang Q., Chan A., Kim S.-B., Wang C.-H., He X., Guo W., Kang J.H., Dechaphunkul A., Li P., Kandil A., Cohen E., Hu G.-Q., Geng Y., Ehrnrooth E., Guo Y.
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/19
©版权所有 ©2017 CSpace - Powered by
CSpace